simvastatin has been researched along with Cardiac Rupture, Traumatic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almansob, MA; Chang, FJ; Chen, W; Ci, HB; Hu, XX; Liu, DH; Ou, JS; Tang, BY; Wang, ZP; Xu, B; Xu, YQ; Yao, FJ; Yao, JP; Zhang, WB; Zhou, L | 1 |
1 trial(s) available for simvastatin and Cardiac Rupture, Traumatic
Article | Year |
---|---|
Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial.
Topics: Adult; Analysis of Variance; Biomarkers; Blood Urea Nitrogen; C-Reactive Protein; Cardiac Surgical Procedures; Cardiotonic Agents; Caveolin 1; China; Creatine Kinase; Creatinine; Female; Heart Injuries; HSP90 Heat-Shock Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Interleukin-8; Male; Middle Aged; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Simvastatin; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Troponin T; Ultrasonography; Ventricular Function, Left | 2012 |